fbpx

Coronavirus

Synairgen to start trial of SNG001 in COVID-19 imminently

Synairgen to start trial of SNG001 in COVID-19 imminently

Coronavirus Conversations: Day 7

Coronavirus Conversations: Day 7

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...
Estimating the generation interval for COVID-19 based on symptom onset data

Estimating the generation interval for COVID-19 based on symptom onset data

A human monoclonal antibody blocking SARS-CoV-2 infection

A human monoclonal antibody blocking SARS-CoV-2 infection

Coronavirus Conversations: Day 6

Coronavirus Conversations: Day 6

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...
Coronavirus Conversations: Day 5

Coronavirus Conversations: Day 5

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...
Coronavirus Conversations: Day 4

Coronavirus Conversations: Day 4

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...
Convalescent plasma as a potential therapy for COVID-19

Convalescent plasma as a potential therapy for COVID-19

Coronavirus Conversations: Day 3

Coronavirus Conversations: Day 3

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...
Coronavirus Conversations: Day 2

Coronavirus Conversations: Day 2

Join me on Facebook, for our daily Coronavirus Community Conversation. I'll share some of the latest news and science, answer your questions, and offer a forum where we can connect in the time of social dist...